CLINICAL, IMMUNOLOGICAL AND MOLECULAR GENETIC DETERMINANTS OF POLYCYSTIC OVARY SYNDROME AND STRATEGIES FOR PERSONALIZED TREATMENT

Read full text Summarise with VIRAT
Authors: N. I. Olimova
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is characterized by hyperandrogenism, ovulatory dysfunction, and metabolic abnormalities. Recent evidence highlights the significant role of immunological and molecular-genetic factors in the pathogenesis of PCOS, emphasizing the importance of personalized therapeutic strategies. Objective. To investigate the clinical, hormonal, immunological, and molecular-genetic determinants of PCOS and to evaluate their significance in the development of personalized treatment approaches. Methods. A total of 120 women of reproductive age were enrolled in the study, including 80 patients diagnosed with PCOS and 40 healthy controls. Clinical assessment included evaluation of menstrual and reproductive history, body mass index (BMI), and ultrasound examination. Hormonal profiling (LH, FSH, testosterone, AMH), immunological markers (IL-6, TNF-α, VEGF-A), and molecular-genetic polymorphisms (VEGF-A and AMH genes) were analyzed. Statistical processing was performed using SPSS software with significance set at p < 0.05. Results. Patients with PCOS demonstrated significantly elevated levels of LH, LH/FSH ratio, testosterone, and AMH compared to controls (p < 0.05). Increased concentrations of pro-inflammatory cytokines IL-6 and TNF-α, as well as VEGF-A, indicated the presence of chronic low-grade inflammation and altered angiogenesis. Unfavorable genotypes of VEGF-A and AMH were significantly more frequent in the PCOS group. Correlation analysis revealed associations between hormonal imbalance, inflammatory activation, and genetic polymorphisms. Conclusion. PCOS is characterized by a complex interplay of endocrine, immunological, and genetic alterations. The findings support the implementation of personalized diagnostic and therapeutic strategies based on the patient’s clinical, immune, and molecular-genetic profile.

Fields of Study & Subjects

Ovarian function and disorders Genetic and Kidney Cyst Diseases Endometriosis Research and Treatment

Publication details

Journal / source
Экономика и социум
Publication date
1 January 2026
Language
EN